MCID: TRM003
MIFTS: 55

Tremor

Categories: Genetic diseases, Neuronal diseases, Oral diseases, Rare diseases

Aliases & Classifications for Tremor

Summaries for Tremor

NINDS : 55 Tremor is an unintentional, rhythmic, muscle movement involving to-and-fro movements of one or more parts of the body. Most tremors occur in the hands, although they can also affect the arms, head, face, voice, torso, and legs. Generally, tremor is caused by a problem in the deep parts of the brain that control movements.  Some forms of tremor are inherited and run in families, while others have no known cause. Sometimes tremor is a symptom of another neurological disorder or a side effect of certain drugs, but the most common form occurs in otherwise healthy people. Excessive alcohol consumption or alcohol withdrawal can kill certain nerve cells, resulting in tremor, especially in the hand. Other causes include an overactive thyroid and the use of certain drugs. Tremor may occur at any age but is most common in middle-aged and older adults. There are several types of tremor, one of the most common of which is essential tremor (sometimes called benign essential tremor). The hands are most often affected but the head, voice, tongue, legs, and trunk may also be involved. Head tremor may be seen as a "yes-yes" or "no-no" motion. Onset is most common after age 40, although symptoms can appear at any age. Parkinsonian tremor is caused by damage to structures within the brain that control movement. The tremor is classically seen as a "pill-rolling" action of the hands but may also affect the chin, face, lips, and legs. Dystonic tremor occurs in individuals of all ages who are affected by dystonia, a movement disorder which causes muscles to be over-active, resulting in abnormal postures or sustained, unwanted movements.

MalaCards based summary : Tremor, also known as tremors, is related to fragile x tremor/ataxia syndrome and fragile x-associated tremor/ataxia syndrome. An important gene associated with Tremor is C19orf12 (Chromosome 19 Open Reading Frame 12), and among its related pathways/superpathways are Neuroscience and Parkinsons Disease Pathway. The drugs Donepezil and Rotigotine have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and testes, and related phenotypes are behavior/neurological and cardiovascular system

MedlinePlus : 44 Tremors are unintentional trembling or shaking movements in one or more parts of your body. Most tremors occur in the hands. You can also have arm, head, face, vocal cord, trunk, and leg tremors. Tremors are most common in middle-aged and older people, but anyone can have them. The cause of tremors is a problem in the parts of the brain that control muscles in the body or in specific parts of the body, such as the hands. They commonly occur in otherwise healthy people. They may also be caused by problems such as Parkinson's disease Dystonia Multiple sclerosis Stroke Traumatic brain injury Alcohol abuse and withdrawal Certain medicines Some forms are inherited and run in families. Others have no known cause. There is no cure for most tremors. Treatment to relieve them depends on their cause. In many cases, medicines and sometimes surgical procedures can reduce or stop tremors and improve muscle control. Tremors are not life-threatening. However, they can be embarrassing and make it hard to perform daily tasks. NIH: National Institute of Neurological Disorders and Stroke

Wikipedia : 77 A tremor is an involuntary, somewhat rhythmic, muscle contraction and relaxation involving oscillations... more...

Related Diseases for Tremor

Diseases in the Tremor family:

Tremor, Hereditary Essential, 1 Tremor, Hereditary Essential, 2
Tremor, Hereditary Essential, 3 Tremor, Hereditary Essential, 4
Tremor, Hereditary Essential, 5 Essential Tremor

Diseases related to Tremor via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 521, show less)
# Related Disease Score Top Affiliating Genes
1 fragile x tremor/ataxia syndrome 34.2 FMR1 LOC108684022
2 fragile x-associated tremor/ataxia syndrome 34.1 FMR1 LOC108684022
3 essential tremor 33.2 DNAJC13 DRD3 FMR1 FUS HTRA2 LRRK2
4 multiple system atrophy 1 32.0 LRRK2 MAPT PRKN SNCA
5 aceruloplasminemia 31.6 ATXN2 FMR1 SNCA
6 parkinson disease 2, autosomal recessive juvenile 31.5 HTRA2 LRRK2 PRKN SNCA
7 movement disease 31.5 DRD3 FMR1 GBA LRRK2 MAPT PRKN
8 parkinson disease 15, autosomal recessive early-onset 31.1 C19orf12 PRKN SNCA
9 dementia, lewy body 30.9 GBA LRRK2 MAPT PRKN SNCA
10 parkinson disease, late-onset 30.2 ATXN2 CHCHD2 DNAJC13 DRD3 GBA HTRA2
11 supranuclear palsy, progressive, 1 30.0 LRRK2 MAPT PRKN SNCA
12 rem sleep behavior disorder 29.8 LRRK2 SNCA
13 postencephalitic parkinson disease 29.6 LRRK2 MAPT SNCA
14 dementia 29.5 ATXN2 FUS GBA LRRK2 MAPT PRKN
15 neuronal intranuclear inclusion disease 29.5 MAPT SNCA
16 amyotrophic lateral sclerosis 1 29.5 ATXN2 FUS MAPT SNCA
17 early-onset parkinson's disease 29.5 GBA LRRK2 PRKN SNCA
18 motor neuron disease 29.4 FUS MAPT SNCA
19 primary orthostatic tremor 12.5
20 tremor, hereditary essential, 4 12.5
21 tremor, hereditary essential, 5 12.5
22 tremor, hereditary essential, 1 12.4
23 tremor, hereditary essential, 2 12.3
24 tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 12.2
25 tremor, hereditary essential, 3 12.1
26 tremor, nystagmus, and duodenal ulcer 12.0
27 tremor of intention, ataxia, and lipofuscinosis 12.0
28 sensorineural hearing loss-early graying-essential tremor syndrome 12.0
29 epilepsy, familial adult myoclonic, 5 12.0
30 leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism 11.9
31 epilepsy, familial adult myoclonic, 1 11.9
32 mental retardation, x-linked, syndromic, cabezas type 11.8
33 epilepsy, familial adult myoclonic, 2 11.7
34 epilepsy, familial adult myoclonic, 6 11.7
35 epilepsy, familial adult myoclonic, 7 11.7
36 mental retardation, autosomal recessive 48 11.7
37 myoclonic cerebellar dyssynergia 11.6
38 psychogenic movement 11.5
39 hereditary geniospasm 11.5
40 dystonia 11.5
41 hypertrophic olivary degeneration 11.4
42 multiple sclerosis 11.4
43 spinal and bulbar muscular atrophy, x-linked 1 11.3
44 cerebellar degeneration 11.3
45 focal dystonia 11.2
46 central pontine myelinolysis 11.2
47 roussy-levy hereditary areflexic dystasia 11.2
48 japanese encephalitis 11.2
49 spinocerebellar ataxia 6 11.2
50 spinocerebellar ataxia 2 11.2
51 wilson disease 11.2
52 neurodegeneration with brain iron accumulation 3 11.2
53 west nile encephalitis 11.2
54 hyperthyroidism 11.2
55 cervical dystonia 11.2
56 epilepsy, familial adult myoclonic, 3 11.1
57 epilepsy, familial adult myoclonic, 4 11.1
58 graves' disease 11.1
59 machado-joseph disease 11.1
60 48,xxyy syndrome 11.1
61 angelman syndrome 11.1
62 dystonia 1, torsion, autosomal dominant 11.1
63 dystonia 12 11.1
64 pelizaeus-merzbacher disease 11.1
65 neurodegeneration with brain iron accumulation 11.1
66 mercury poisoning 11.1
67 cerebral beriberi 11.1
68 leukoencephalopathy with dystonia and motor neuropathy 11.1
69 spinocerebellar ataxia 29 11.0
70 basal ganglia calcification, idiopathic, 1 11.0
71 spinocerebellar ataxia 27 11.0
72 ramsay hunt syndrome i 11.0
73 polr3-related leukodystrophy 11.0
74 neuroaxonal dystrophy renal tubular acidosis 11.0
75 benign adult familial myoclonic epilepsy 11.0
76 spinocerebellar ataxia 31 10.9
77 dystonia 11, myoclonic 10.9
78 parkinson disease 1, autosomal dominant 10.9
79 cerebellar ataxia, cayman type 10.9
80 spinocerebellar ataxia 12 10.9
81 nemaline myopathy 5 10.9
82 parkinson disease 7, autosomal recessive early-onset 10.9
83 blepharospasm, benign essential 10.9
84 spinocerebellar ataxia 21 10.9
85 parkinsonism-dystonia, infantile, 1 10.9
86 spinocerebellar ataxia 35 10.9
87 parkinson disease 19a, juvenile-onset 10.9
88 myopathy with extrapyramidal signs 10.9
89 spinocerebellar ataxia 40 10.9
90 parkinson disease 21 10.9
91 spastic paraplegia 9b, autosomal recessive 10.9
92 developmental delay and seizures with or without movement abnormalities 10.9
93 leukodystrophy, hypomyelinating, 16 10.9
94 von economo's disease 10.9
95 adcy5-related dyskinesia 10.9
96 x-linked dystonia-parkinsonism/lubag 10.9
97 deep brain stimulation for movement disorders 10.9
98 cerebral amyloid angiopathy, itm2b-related, 2 10.8
99 dystonia, dopa-responsive 10.8
100 myopathy, distal, 1 10.8
101 ceroid lipofuscinosis, neuronal, 4b, autosomal dominant 10.8
102 optic atrophy 3, autosomal dominant 10.8
103 cerebral amyloid angiopathy, itm2b-related, 1 10.8
104 gillespie syndrome 10.8
105 argininosuccinic aciduria 10.8
106 agenesis of the corpus callosum with peripheral neuropathy 10.8
107 glutathionuria 10.8
108 kuru 10.8
109 metachromatic leukodystrophy 10.8
110 parkinson-dementia syndrome 10.8
111 hyperphenylalaninemia, bh4-deficient, d 10.8
112 spinocerebellar degeneration and corneal dystrophy 10.8
113 sudanophilic cerebral sclerosis 10.8
114 wernicke-korsakoff syndrome 10.8
115 mental retardation, x-linked, syndromic 13 10.8
116 brunner syndrome 10.8
117 neurodegeneration with brain iron accumulation 5 10.8
118 parkinsonism with spasticity, x-linked 10.8
119 mental retardation, x-linked 12 10.8
120 anemia, sideroblastic, and spinocerebellar ataxia 10.8
121 spinocerebellar ataxia, x-linked 4 10.8
122 leber optic atrophy and dystonia 10.8
123 hypomagnesemia 1, intestinal 10.8
124 myotonic dystrophy 2 10.8
125 spinocerebellar ataxia 10 10.8
126 cerebral palsy, ataxic, autosomal recessive 10.8
127 parkinson disease 4, autosomal dominant 10.8
128 parkinson disease 6, autosomal recessive early-onset 10.8
129 spinocerebellar ataxia 15 10.8
130 kufor-rakeb syndrome 10.8
131 parkinson disease 8, autosomal dominant 10.8
132 spinocerebellar ataxia 19 10.8
133 dystonia, juvenile-onset 10.8
134 parkinson disease 11, autosomal dominant 10.8
135 spinocerebellar ataxia 20 10.8
136 striatal degeneration, autosomal dominant 1 10.8
137 parkinson disease 13, autosomal dominant 10.8
138 dystonia, dopa-responsive, due to sepiapterin reductase deficiency 10.8
139 cerebral creatine deficiency syndrome 2 10.8
140 nephronophthisis-like nephropathy 1 10.8
141 parkinson disease 5, autosomal dominant 10.8
142 parkinson disease 17 10.8
143 parkinson disease 18, autosomal dominant 10.8
144 basal ganglia calcification, idiopathic, 4 10.8
145 basal ganglia calcification, idiopathic, 5 10.8
146 triosephosphate isomerase deficiency 10.8
147 parkinson disease 20, early-onset 10.8
148 encephalopathy, progressive, with or without lipodystrophy 10.8
149 basal ganglia calcification, idiopathic, 6 10.8
150 leukodystrophy, hypomyelinating, 11 10.8
151 parkinson disease 22, autosomal dominant 10.8
152 parkinson disease 23, autosomal recessive early-onset 10.8
153 jaberi-elahi syndrome 10.8
154 basal ganglia calcification, idiopathic, 7, autosomal recessive 10.8
155 neurodevelopmental disorder with impaired speech and hyperkinetic movements 10.8
156 cerebral palsy 10.8
157 powassan encephalitis 10.8
158 spinocerebellar ataxia type 19/22 10.8
159 syndromic x-linked intellectual disability cabezas type 10.8
160 primary hypomagnesemia 10.8
161 sleeping sickness 10.8
162 louping ill 10.8
163 st. louis encephalitis 10.8
164 thyroid crisis 10.8
165 cockayne syndrome 10.8
166 unverricht-lundborg syndrome 10.8
167 striatonigral degeneration 10.8
168 leber hereditary optic neuropathy 10.8
169 autosomal dominant leukodystrophy with autonomic disease 10.8
170 primary familial brain calcification 10.8
171 adult neuronal ceroid lipofuscinosis 10.8
172 aids dementia complex 10.8
173 cerebral folate deficiency 10.8
174 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids 10.8
175 cockayne syndrome type i 10.8
176 cockayne syndrome type ii 10.8
177 cockayne syndrome type iii 10.8
178 dyt-tor1a 10.8
179 early-onset parkinsonism-intellectual disability syndrome 10.8
180 harding ataxia 10.8
181 isolated congenital megalocornea 10.8
182 karak syndrome 10.8
183 nbia/dyt/park-pla2g6 10.8
184 phosphoglycerate kinase deficiency 10.8
185 wells-jankovic syndrome 10.8
186 korsakoff's amnesic syndrome 10.8
187 multiple system atrophy with orthostatic hypotension 10.8
188 myelinoclastic diffuse sclerosis 10.8
189 extrapontine myelinolysis 10.8
190 serotonin syndrome 10.8
191 ataxia and polyneuropathy, adult-onset 10.7
192 myoclonus 10.5
193 epilepsy 10.5
194 neuropathy 10.3
195 depression 10.2
196 anxiety 10.2
197 spasmodic dysphonia 10.2
198 aging 10.2
199 muscular atrophy 10.2
200 primary lateral sclerosis, adult, 1 10.2 MAPT SNCA
201 torticollis 10.2
202 fragile x syndrome 10.2
203 parkinson disease 10 10.2 LRRK2 PRKN SNCA
204 echolalia 10.1 FMR1 MAPT
205 pathologic nystagmus 10.1
206 encephalopathy 10.1
207 dysautonomia 10.1 DNAJC13 GBA SNCA
208 corticobasal degeneration 10.1 GBA LRRK2 MAPT
209 tardive dyskinesia 10.1
210 restless legs syndrome 10.1
211 autosomal dominant cerebellar ataxia 10.1
212 gaucher's disease 10.1 GBA PRKN SNCA
213 alzheimer disease 10.1
214 pick disease of brain 10.1 FUS MAPT SNCA
215 charcot-marie-tooth disease 10.1
216 tooth disease 10.1
217 choreatic disease 10.1
218 polyneuropathy 10.0
219 cerebellar disease 10.0
220 progressive multifocal leukoencephalopathy 10.0
221 pontine hemorrhage 10.0
222 disease of mental health 10.0 DRD3 FMR1 MAPT SNCA
223 hereditary late-onset parkinson disease 10.0 DNAJC13 GBA LRRK2 SNCA
224 alexander disease 10.0
225 graves disease 1 10.0
226 spinal muscular atrophy 10.0
227 arachnoid cysts 10.0
228 headache 10.0
229 parkinson disease 3, autosomal dominant 10.0 LRRK2 MAPT PRKN SNCA
230 frontotemporal dementia 10.0 FUS LRRK2 MAPT SNCA
231 seizures, benign familial neonatal, 1 9.9
232 gilles de la tourette syndrome 9.9
233 schizophrenia 9.9
234 chronic inflammatory demyelinating polyneuropathy 9.9
235 hydrocephalus 9.9
236 intermittent claudication 9.9
237 hypogonadotropic hypogonadism 9.9
238 lateral sclerosis 9.9
239 demyelinating polyneuropathy 9.9
240 blepharospasm 9.9
241 peripheral nervous system disease 9.9
242 encephalitis 9.9
243 spasticity 9.9
244 nervous system disease 9.9 LRRK2 MAPT PRKN SNCA
245 central nervous system disease 9.9 LRRK2 MAPT PRKN SNCA
246 frontotemporal dementia and/or amyotrophic lateral sclerosis 1 9.9 ATXN2 FUS MAPT
247 neurodegeneration with brain iron accumulation 1 9.9
248 canavan disease 9.9
249 premature ovarian failure 1 9.9
250 stroke, ischemic 9.9
251 body mass index quantitative trait locus 1 9.9
252 muscle disorders 9.9
253 stuttering 9.9
254 leukodystrophy 9.9
255 social phobia 9.9
256 chronic progressive external ophthalmoplegia 9.9
257 benign shuddering attacks 9.9
258 astrocytoma 9.9
259 myopathy 9.9
260 polyradiculoneuropathy 9.9
261 intracranial hypotension 9.9
262 benign ependymoma 9.9
263 athetosis 9.9
264 ependymoma 9.9
265 fetal methylmercury syndrome 9.9
266 glioma 9.9
267 hemifacial spasm 9.9
268 polyneuropathy associated with igm monoclonal gammapathy with anti-mag 9.9
269 spontaneous intracranial hypotension 9.9
270 neurodegeneration with brain iron accumulation 4 9.8 C19orf12 DNAJC13
271 epidermoid cysts 9.8
272 klippel-trenaunay-weber syndrome 9.8
273 migraine with or without aura 1 9.8
274 celiac disease 1 9.8
275 cerebellar hypoplasia 9.8
276 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
277 friedreich ataxia 1 9.8
278 hydrocephalus due to congenital stenosis of aqueduct of sylvius 9.8
279 hydrocephalus, normal-pressure 9.8
280 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 9.8
281 epilepsy, idiopathic generalized 10 9.8
282 muscle hypertrophy 9.8
283 rigidity and multifocal seizure syndrome, lethal neonatal 9.8
284 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
285 liver cirrhosis 9.8
286 niemann-pick disease 9.8
287 2-hydroxyglutaric aciduria 9.8
288 vitamin b12 deficiency 9.8
289 withdrawal disorder 9.8
290 aphasia 9.8
291 apraxia 9.8
292 sensorineural hearing loss 9.8
293 hemiplegia 9.8
294 sarcoma 9.8
295 hepatic coma 9.8
296 guillain-barre syndrome 9.8
297 diarrhea 9.8
298 neurosarcoidosis 9.8
299 hepatic encephalopathy 9.8
300 multiple cranial nerve palsy 9.8
301 status epilepticus 9.8
302 melanoma 9.8
303 adenocarcinoma 9.8
304 early myoclonic encephalopathy 9.8
305 syringomyelia 9.8
306 germinoma 9.8
307 agnosia 9.8
308 anterior horn cell disease 9.8
309 chronic inflammatory demyelinating polyradiculoneuropathy 9.8
310 acquired immunodeficiency syndrome 9.8
311 exophthalmos 9.8
312 toxoplasmosis 9.8
313 congenital hydrocephalus 9.8
314 fmr1-related primary ovarian insufficiency 9.8
315 pilocytic astrocytoma 9.8
316 spastic paraparesis 9.8
317 hypoxia 9.8
318 dysphagia 9.8
319 alcohol dependence 9.6
320 blood group, colton system 9.6
321 hepatocellular carcinoma 9.6
322 carpal tunnel syndrome 9.6
323 sotos syndrome 1 9.6
324 coumarin resistance 9.6
325 dentatorubral-pallidoluysian atrophy 9.6
326 erythermalgia, primary 9.6
327 hashimoto thyroiditis 9.6
328 huntington disease 9.6
329 inclusion body myositis 9.6
330 kabuki syndrome 1 9.6
331 myositis 9.6
332 obsessive-compulsive disorder 9.6
333 hyperkalemic periodic paralysis 9.6
334 prostate cancer 9.6
335 proteus syndrome 9.6
336 stiff-person syndrome 9.6
337 strabismus 9.6
338 thrombophilia due to thrombin defect 9.6
339 trigeminal neuralgia 9.6
340 abetalipoproteinemia 9.6
341 chiari malformation type ii 9.6
342 ataxia-telangiectasia 9.6
343 autism 9.6
344 behr syndrome 9.6
345 bile acid synthesis defect, congenital, 4 9.6
346 cystic fibrosis 9.6
347 l-2-hydroxyglutaric aciduria 9.6
348 hypoascorbemia 9.6
349 krabbe disease 9.6
350 chylomicron retention disease 9.6
351 myasthenia gravis 9.6
352 myeloma, multiple 9.6
353 epilepsy, progressive myoclonic, 4, with or without renal failure 9.6
354 niemann-pick disease, type a 9.6
355 niemann-pick disease, type c1 9.6
356 ocular motor apraxia 9.6
357 3-methylglutaconic aciduria, type iii 9.6
358 papilloma of choroid plexus 9.6
359 phenylketonuria 9.6
360 polyglucosan body neuropathy, adult form 9.6
361 pulmonary alveolar microlithiasis 9.6
362 scapuloperoneal myopathy, x-linked dominant 9.6
363 nance-horan syndrome 9.6
364 rett syndrome 9.6
365 helicobacter pylori infection 9.6
366 asthma 9.6
367 suppression of tumorigenicity 12 9.6
368 prostate cancer, hereditary, 8 9.6
369 apraxia of eyelid opening 9.6
370 reflex sympathetic dystrophy 9.6
371 spastic paraplegia 11, autosomal recessive 9.6
372 meningioma, familial 9.6
373 major depressive disorder 9.6
374 prostate cancer, hereditary, 6 9.6
375 spastic paraplegia 31, autosomal dominant 9.6
376 malaria 9.6
377 charcot-marie-tooth disease, type 4j 9.6
378 porphyria, acute hepatic 9.6
379 mononeuropathy of the median nerve, mild 9.6
380 alpha-methylacyl-coa racemase deficiency 9.6
381 spinocerebellar ataxia, autosomal recessive 14 9.6
382 alacrima, achalasia, and mental retardation syndrome 9.6
383 polyglucosan body myopathy 1 with or without immunodeficiency 9.6
384 spinocerebellar ataxia 42 9.6
385 phenytoin toxicity 9.6
386 west syndrome 9.6
387 arteriovenous fistula 9.6
388 bipolar disorder 9.6
389 brain injury 9.6
390 crohn's disease 9.6
391 hemangioma 9.6
392 hereditary ataxia 9.6
393 hereditary spastic paraplegia 9.6
394 lymphedema 9.6
395 pancreas adenocarcinoma 9.6
396 pemphigus foliaceus 9.6
397 pulmonary emphysema 9.6
398 inflammatory bowel disease 9.6
399 segmental dystonia 9.6
400 spasmodic dystonia 9.6
401 hemidystonia 9.6
402 autism spectrum disorder 9.6
403 amyotrophic lateral sclerosis type 6 9.6
404 basal ganglia calcification 9.6
405 scoliosis 9.6
406 ptosis 9.6
407 hyperekplexia 9.6
408 thrombosis 9.6
409 asymptomatic neurosyphilis 9.6
410 cysticercosis 9.6
411 obsessive-compulsive personality disorder 9.6
412 spastic diplegia 9.6
413 brucellosis 9.6
414 arteriovenous malformation 9.6
415 spinal meningioma 9.6
416 autonomic neuropathy 9.6
417 lyme disease 9.6
418 patulous eustachian tube 9.6
419 bell's palsy 9.6
420 acoustic neuroma 9.6
421 locked-in syndrome 9.6
422 plasmodium vivax malaria 9.6
423 carotid stenosis 9.6
424 ehlers-danlos syndrome 9.6
425 megaloblastic anemia 9.6
426 kwashiorkor 9.6
427 beriberi 9.6
428 squamous cell papilloma 9.6
429 algoneurodystrophy 9.6
430 obstructive hydrocephalus 9.6
431 generalized anxiety disorder 9.6
432 neuroleptic malignant syndrome 9.6
433 hypothyroidism 9.6
434 cholera 9.6
435 personality disorder 9.6
436 conversion disorder 9.6
437 neuritis 9.6
438 childhood absence epilepsy 9.6
439 hypogonadism 9.6
440 neuroma 9.6
441 brain germinoma 9.6
442 thrombocytosis 9.6
443 focal epilepsy 9.6
444 dyspepsia 9.6
445 west nile fever 9.6
446 wernicke encephalopathy 9.6
447 papilloma 9.6
448 tic disorder 9.6
449 bruxism 9.6
450 thoracic outlet syndrome 9.6
451 neurilemmoma 9.6
452 complex regional pain syndrome 9.6
453 ischemia 9.6
454 gm2 gangliosidosis 9.6
455 mood disorder 9.6
456 brain stem infarction 9.6
457 duodenal obstruction 9.6
458 erdheim-chester disease 9.6
459 neuromuscular disease 9.6
460 hypokalemia 9.6
461 dysgraphia 9.6
462 secretory meningioma 9.6
463 ulnar neuropathy 9.6
464 cavernous hemangioma 9.6
465 pilocytic astrocytoma of cerebellum 9.6
466 poliomyelitis 9.6
467 infertility 9.6
468 internuclear ophthalmoplegia 9.6
469 scrapie 9.6
470 pneumonia 9.6
471 panic disorder 9.6
472 cerebral meningioma 9.6
473 thyroiditis 9.6
474 axonal neuropathy 9.6
475 monoclonal gammopathy of uncertain significance 9.6
476 hypogonadotropism 9.6
477 frontal convexity meningioma 9.6
478 pellagra 9.6
479 chronic fatigue syndrome 9.6
480 herpes simplex 9.6
481 learning disability 9.6
482 macroglobulinemia 9.6
483 mechanical strabismus 9.6
484 hypopituitarism 9.6
485 hemorrhoid 9.6
486 lingual-facial-buccal dyskinesia 9.6
487 eosinophilia-myalgia syndrome 9.6
488 hypereosinophilic syndrome 9.6
489 microcephaly 9.6
490 adult polyglucosan body disease 9.6
491 familial paroxysmal nonkinesigenic dyskinesia 9.6
492 1q duplications 9.6
493 amyloid neuropathy 9.6
494 bobble-head doll syndrome 9.6
495 brainstem auditory evoked responses 9.6
496 chiari malformation 9.6
497 chromosomal triplication 9.6
498 gangliosidosis 9.6
499 hemiplegic migraine 9.6
500 herpes simplex encephalitis 9.6
501 lipogranulomatosis 9.6
502 myasthenia gravis congenital 9.6
503 neurosyphilis 9.6
504 paraneoplastic cerebellar degeneration 9.6
505 pineal cyst 9.6
506 proximal spinal muscular atrophy 9.6
507 sandifer syndrome 9.6
508 hypotonia 9.6
509 paroxysmal choreoathetosis 9.6
510 spinocerebellar degeneration 9.6
511 whiplash 9.6
512 cavernous malformation 9.6
513 cerebral atrophy 9.6
514 dementia - subcortical 9.6
515 audiogenic seizures 9.6
516 posttransplant acute limbic encephalitis 9.6
517 trisomy 1q 9.6
518 multiple system atrophy, cerebellar type 9.6
519 early-onset generalized limb-onset dystonia 9.6
520 manganese poisoning 9.6
521 early-onset schizophrenia 9.6

Graphical network of the top 20 diseases related to Tremor:



Diseases related to Tremor

Symptoms & Phenotypes for Tremor

MGI Mouse Phenotypes related to Tremor:

47 (showing 4, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.03 ATXN2 CNTN2 DRD3 FMR1 GBA HTRA2
2 cardiovascular system MP:0005385 9.81 DRD3 GBA HTRA2 LRRK2 MAPT PRKN
3 cellular MP:0005384 9.65 FMR1 GBA HTRA2 LRRK2 MAPT MPZ
4 nervous system MP:0003631 9.44 ATXN2 CNTN2 DRD3 FMR1 GBA HTRA2

Drugs & Therapeutics for Tremor

Drugs for Tremor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 573, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Donepezil Approved Phase 4 120014-06-4 3152
2
Rotigotine Approved Phase 4,Phase 2 99755-59-6, 92206-54-7 57537
3
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 62-31-7, 51-61-6 681
4
Acetylcholine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-84-3 187
5
Carbetocin Approved, Investigational Phase 4 37025-55-1 16681432 71715
6
Oxytocin Approved, Vet_approved Phase 4,Phase 2 50-56-6 53477758 439302
7
Ropivacaine Approved Phase 4 84057-95-4 175805 71273
8
Propranolol Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 525-66-6 4946
9
Gabapentin Approved, Investigational Phase 4,Phase 3,Not Applicable 60142-96-3 3446
10
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 137-58-6 3676
11
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 113775-47-6 5311068 68602
12
Risperidone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 106266-06-2 5073
13
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
14
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Not Applicable 22916-47-8 4189
15
Memantine Approved, Investigational Phase 4,Not Applicable 19982-08-2 4054
16
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 2,Phase 1 148553-50-8 5486971
17
Levodopa Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 59-92-7 6047
18
Entacapone Approved, Investigational Phase 4,Phase 3 130929-57-6 5281081
19
Carbidopa Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 28860-95-9 34359
20
Glimepiride Approved Phase 4,Phase 3 93479-97-1 3476
21
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1 657-24-9 14219 4091
22
Gliclazide Approved Phase 4,Phase 3 21187-98-4 3475
23
Glyburide Approved Phase 4,Phase 3 10238-21-8 3488
24
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-03-3
25
Procaterol Approved, Investigational Phase 4 72332-33-3 688561
26
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 5754
27
Pramipexole Approved, Investigational Phase 4,Phase 3 104632-26-0 119570 59868
28
Methadone Approved, Illicit Phase 4,Phase 3,Phase 1 76-99-3 4095
29
Morphine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 57-27-2 5288826
30
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 93-14-1 3516
31
Ropinirole Approved, Investigational Phase 4,Phase 3 91374-20-8, 91374-21-9 5095 497540
32
Fluticasone Approved, Experimental Phase 4,Phase 3 90566-53-3 62924
33
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
34
Rasagiline Approved Phase 4,Phase 3,Phase 2 136236-51-6 3052776
35
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
36
Vancomycin Approved Phase 4,Phase 3 1404-90-6 14969 441141
37
Daptomycin Approved, Investigational Phase 4,Phase 3 103060-53-3 16129629
38
Zinc Approved, Investigational Phase 4,Phase 2,Not Applicable 7440-66-6 32051
39
Insulin Lispro Approved Phase 4 133107-64-9
40
Insulin glargine Approved Phase 4,Phase 2 160337-95-1
41
Terbutaline Approved Phase 4 23031-25-6 5403
42
Trimethobenzamide Approved, Investigational Phase 4 138-56-7 5577
43
Apomorphine Approved, Investigational Phase 4 58-00-4, 41372-20-7 6005
44
Topiramate Approved Phase 4,Phase 3 97240-79-4 5284627
45
Phentermine Approved, Illicit Phase 4,Not Applicable 122-09-8 4771
46
Levetiracetam Approved, Investigational Phase 4,Phase 1,Phase 2 102767-28-2 441341
47
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
48
Lamotrigine Approved, Investigational Phase 4 84057-84-1 3878
49
Paroxetine Approved, Investigational Phase 4,Phase 3 61869-08-7 43815
50
Sertraline Approved Phase 4,Not Applicable 79617-96-2 68617
51
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 104987-11-3 6473866 445643 439492
52
Lithium carbonate Approved Phase 4,Phase 2,Phase 1 554-13-2
53
Liraglutide Approved Phase 4,Phase 2,Phase 1,Not Applicable 204656-20-2 44147092
54
Racepinephrine Approved Phase 4,Phase 1,Phase 2 329-65-7 838
55
Epinephrine Approved, Vet_approved Phase 4,Phase 1,Phase 2 51-43-4 5816
56
Aripiprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 129722-12-9 60795
57
alemtuzumab Approved, Investigational Phase 4 216503-57-0
58
Baclofen Approved Phase 4,Not Applicable,Early Phase 1 1134-47-0 2284
59
Prednisone Approved, Vet_approved Phase 4,Phase 1 53-03-2 5865
60
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
61
Lorazepam Approved Phase 4,Phase 1,Not Applicable 846-49-1 3958
62
Bupivacaine Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 38396-39-3, 2180-92-9 2474